Education
- Jul 2007–Jul 2012 Residency Program in Obstetrics and Gynecology -70/70 cum laude – Università degli Studi of Milan
- Apr 2011– Oct 2011 Visiting Research Fellow at The University of Texas MD Anderson Cancer Center – Gynecologic Oncology and Reproductive Medicine Department – Huston (TX), USA
- Jul 2006 Medical Doctor – 110/110 cum laude – Università degli Studi of Milan (Italy)
- Feb 2005–Jun 2005 SOCRATES/ERASMUS Project – Universidad Autonoma de Madrid – Facultad de Medicina y Cirugia
Academic background
- Current role – Assistant Professor of Gynecology and Obstetrics (tenure track – RTT)
- Jul 2020 National Scientific Qualification for Associate and Full Professorship in Gynecology and Obstetrics – Ministry of Education, University and Research: Italy
- Jan 2016 – Dec 2018 European Society of Gynaecological Oncology (ESGO) Training Fellowship at Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori – Milan ESGO certification as an accreditated European Gynaecological Oncologist
- Feb 2017 – Jun 2017 Faculty at university specialization course “Linfologia Clinica” – Università degli Studi di Milano
- Aug 2012 – Jul 2013 Research Assignment: “Predittori Biologici di Risposta alla Chemioterapia nel Ca della Cervice Uterina” – Gynecologic Oncology Dept – Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori – Milan
- Apr 2011 – Oct 2011 Visiting Research Fellow at The University of Texas MD Anderson Cancer Center – Gynecologic Oncology and Reproductive Medicine Department – Huston (TX), USA
Membership and leadership roles
- European Commission Funding & Tenders – Expert Evaluator EX2021D431400 since 2021
- EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY – Expert in Medical Devices since 2021
- EURACAN – European Reference Networks (ERN) for Rare and Low Prevalence Complex Diseases (European commission) European Reference Networks – the ERN for all rare adult solid cancers – member since 2022
- Internal Review Board (IRB) Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori – Milan – Expert component since 2024
- European Nework of Young Gynaecologic Oncologists (ENYGO) National Representative (NATREP) of Italy 2021-2023
- Associate Editor e Topic Editor in Women’s Cancer/Gynecological Oncology – Frontiers in Oncology since 2018
- Editorial Board Member. Experimental and Therapeutic Medicine
- Editorial Board Member. International Journal of Gynecological Cancer
- Società Italiana di Oncologia Ginecologica (SIOG) –Board Member since 2015
- McMaster Online Rating of Evidence (MORE), McMaster University – Canada – Rater since 2017
- AAGL’s Oncology Special Interest Group – member since 2011
- European Society of Gynaecological Oncology (ESGO) – member since 2020
- Principal Investigator at INT-Milan: “Patient Outcomes following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer: a GO SOAR led Study (GO SOAR2)”. Coordinating Center Centre team based at NHS Grampian, UK, protocol INT 11-23
- Principal Investigator at INT-Milan: “Determining Post-Operative Morbidity & Mortality Following Gynaecological Oncology Surgery: a Multicentre, International, Prospective Cohort Study Led by the Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR)”. Coordinating Center Centre team based at NHS Grampian, UK, protocol INT 46-21
- Principal Investigator at INT-Milan: “Cytoreductive Surgery in Advanced Endometrial Cancer. Multicenter Retrospective Study.” Coordinatig center: ISTITUTO NAZIONALE TUMORI NAPOLI, protocol INT 95-20
- Principal Investigator and Study coordinator of a multicenter study ““The role of micrometastasis and isolated tumor cells (ITCs) in uterine cancers (endometrial/cervical) submitted to sentinel lymph nodes (SLN) procedure: an observational study” Coordinating Center Fondazione IRCCS Istituto Nazionale Tumori – Milano Protocol INT 135-19v2.0 NCT04403867
- Principal Investigator ““The role of micrometastasis and isolated tumor cells (ITCs) in uterine cancers (endometrial/cervical) submitted to sentinel lymph nodes (SLN) procedure: an observational study” Fondazione IRCCS Istituto Nazionale Tumori – Milano Protocol INT 135-19
- Principal Investigator at INT-Milan: “Radical Abdominal Hysterectomy vs Laparoscopic Radical Hysterectomy in cervical cancer stage IA1-IB1: Does tumor size matter? A Multicenter Cohort study.” Coordianting center: Instituto Nacional de Cancerología (INC) Colombia, protocol INT 61-19
Grants and awards
- International Journal of Gynecological Cancer (IJGC) Top Editorial Board Member Award 2021
- International Journal of Gynecological Cancer (IJGC) Top Reviewer Award 2020
- Publons Top Peer Reviewer – Clinical Medicine 2019
- Publons Top Peer Reviewer – Cross Fields 2019
- Publons Peer Review Award 2018
- Lega Italiana per la Lotta contro i Tumori – Mantova, borsa di studio 2007
Dr Martinelli is a Gynecologist with special interest in Gynecologic Oncology. He is an expert in surgical techniques and innovative approaches, he actively participated in the introduction of sentinel nodes procedure in endometrial cancer. He had a 20 year career experience in cancer centers such us Fondazione IRCCS Istituto Nazionale dei Tumori of Milan, MD Anderson Cancer Center – Huston (TX) – USA. During his training he was awarded the certification of European Gynecologic Oncologist form the European Society of Gynaecological Oncology (ESGO).
In his early research career, he focused on cervical cancer studies, concentrating on nerve anatomy preservation. He then specialized in sentinel node mapping in gynecologic oncology. He is now considered an expert acting as external reviewer for the European guidelines on gynecologic cancer management. He is member of major national and international gynecologic oncology society as well as editorial board member of the official journal (International Journal of Gynecological Cancer) of the two main gyn-onc societies (IGCS and ESGO) and he is committed in teaching and spreading knowledge all over the world with tough connections with LATAM and US. Furthermore, he is an European Commission expert in medical devices and and expert evaluator of EU projects in medicine and AI.
In May 2024, Dr Martinelli joined Humanitas University as Assistant Professor (RTT) of Gynecologic and Obstetrics and Director of the Gynecologic Oncology Surgical division at Humanitas San Pio X.
Main research fields:
- Sentinel node mapping in gynecologic oncology
- Innovations in surgical techniques and devices
- Cytoreductive surgery
- Oncofertility
- Social media in gynecologic oncology
- Fotopoulou C, Eriksson AG, Planchamp F, Morice P, Taylor A, Sturdza A, Florin Coza O, Halaska MJ, Martinelli F, Armbrust R, Chargari C. European Society of Gynaecological Oncology expanded quality indicators and accreditation for cervical cancer management. Int J Gynecol Cancer. 2024 Feb 23:ijgc-2024-005293. doi: 10.1136/ijgc-2024-005293. Epub ahead of print. PMID: 38395448
- NIHR Global Health Unit on Global Surgery; COVIDSurg Collaborative. . [Martinelli F. Local collabolator]. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries. Lancet. 2022 Nov 5;400(10363):1607-1617. doi: 10.1016/S0140-6736(22)01846-3. Epub 2022 Oct 31.PMID: 36328042 PMC9621702
- Martinelli F, Ditto A, Filippi F, Vinti D, Bogani G, Leone Roberti Maggiore U, Evangelista M, Signorelli M, Chiappa V, Lopez S, Somigliana E, Raspagliesi F. Conization and lymph node evaluation as a fertility-sparing treatment for early stage cervical cancer. Int J Gynecol Cancer. 2021 Mar;31(3):457-461. doi: 10.1136/ijgc-2020-001740. PMID: 33649014
- Martinelli F, Garbi A. Change in practice in gynecologic oncology during the COVID-19 pandemic: a social media survey. Int J Gynecol Cancer. 2020 Aug;30(8):1101-1107. doi: 10.1136/ijgc-2020-001585. Epub 2020 Jun 7. PMID: 32513664; PMCID: PMC7299657
- Martinelli F, Ditto A, Signorelli M, Bogani G, Chiappa V, Lorusso D, Scaffa C, Recalcati D, Perotto S, Haeusler E, Raspagliesi F. Sentinel node mapping in endometrial cancer following Hysteroscopic injection of tracers: A single center evaluation over 200 cases. Gynecol Oncol. 2017 Sep;146(3):525-530. doi: 10.1016/j.ygyno.2017.06.014. Epub 2017 Jul 5. PMID: 28625394.